Asymmetry Capital Management as of Dec. 31, 2015
Portfolio Holdings for Asymmetry Capital Management
Asymmetry Capital Management holds 17 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ptc Therapeutics I (PTCT) | 11.6 | $7.7M | 237k | 32.40 | |
| XenoPort | 10.8 | $7.1M | 1.3M | 5.49 | |
| Quest Diagnostics Incorporated (DGX) | 10.1 | $6.6M | 93k | 71.14 | |
| Acorda Therapeutics | 9.4 | $6.2M | 146k | 42.78 | |
| Centene Corporation (CNC) | 8.6 | $5.7M | 86k | 65.81 | |
| Teva Pharmaceutical Industries (TEVA) | 7.5 | $4.9M | 75k | 65.64 | |
| UnitedHealth (UNH) | 6.3 | $4.2M | 36k | 117.64 | |
| Edwards Lifesciences (EW) | 5.6 | $3.7M | 47k | 78.98 | |
| Nevro (NVRO) | 5.6 | $3.7M | 55k | 67.51 | |
| Alkermes (ALKS) | 3.5 | $2.3M | 29k | 79.39 | |
| Neurocrine Biosciences (NBIX) | 3.5 | $2.3M | 41k | 56.57 | |
| Impax Laboratories | 3.3 | $2.2M | 51k | 42.76 | |
| Aerie Pharmaceuticals | 3.2 | $2.1M | 86k | 24.36 | |
| Pacific Biosciences of California (PACB) | 2.9 | $1.9M | 145k | 13.13 | |
| Amicus Therapeutics (FOLD) | 2.9 | $1.9M | 195k | 9.70 | |
| Anacor Pharmaceuticals In | 2.7 | $1.8M | 16k | 112.95 | |
| Synergy Pharmaceuticals | 2.6 | $1.7M | 303k | 5.67 |
